EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Association Between Autism Spectrum Disorders and Cardiometabolic Diseases

Chathurika S Dhanasekara, Dominic Ancona, Leticia Cortes, Amy Hu, Afrina H Rimu, Christina Robohm-Leavitt, Drew Payne, Sarah M Wakefield, Ann M Mastergeorge, Chanaka N Kahathuduwa

JAMA Pediatrics · 01.03.2023 · 177 (3) · 248

DOI: 10.1001/jamapediatrics.2022.5629 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA Pediatrics, erschienen am 01.03.2023. Verfasst von Chathurika S Dhanasekara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Science and Primary Care, School of Health Professions, Texas Tech University Health Sciences Center, Lubbock. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Autism Spectrum Disorder, Autistic Disorder, Stroke. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Although the increased risk of obesity among individuals with autism has been well established, evidence on the association between autism, cardiometabolic disorders, and obesity remains inconclusive.

Objective

To examine the association between autism spectrum disorders and cardiometabolic diseases in a systematic review and meta-analysis. Data Sources PubMed, Scopus, Web of Science, ProQuest, Embase, and Ovid databases were searched from inception through July 31, 2022, without restrictions on date of publication or language. Study Selection Observational or baseline data of interventional studies reporting the prevalence of cardiometabolic risk factors (ie, diabetes, hypertension, dyslipidemia, atherosclerotic macrovascular disease) among children and/or adults with autism and matched with participants without autism were included. Data Extraction and Synthesis Screening, data extraction, and quality assessment were performed independently by at least 2 researchers. DerSimonian-Laird random-effects meta-analyses were performed using the meta package in R. Main Outcomes and Measures Relative risks (RRs) of diabetes, hypertension, dyslipidemia, and atherosclerotic macrovascular disease among individuals with autism were the primary outcomes. Secondary outcomes included the RR of type 1 and type 2 diabetes, heart disease, stroke, and peripheral vascular disease.

Results

A total of 34 studies were evaluated and included 276 173 participants with autism and 7 733 306 participants without autism (mean [range] age, 31.2 [3.8-72.8] years; pooled proportion [range] of female individuals, 47% [0-66%]). Autism was associated with greater risks of developing diabetes overall (RR, 1.57; 95% CI, 1.23-2.01; 20 studies), type 1 diabetes (RR, 1.64; 95% CI, 1.06-2.54; 6 studies), and type 2 diabetes (RR, 2.47; 95% CI, 1.30-4.70; 3 studies). Autism was also associated with increased risks of dyslipidemia (RR, 1.69; 95% CI, 1.20-2.40; 7 studies) and heart disease (RR, 1.46; 95% CI, 1.42-1.50; 3 studies). Yet, there was no significantly associated increased risk of hypertension and stroke with autism (RR, 1.22; 95% CI, 0.98-1.52; 12 studies; and RR, 1.19; 95% CI, 0.63-2.24; 4 studies, respectively). Meta-regression analyses revealed that children with autism were at a greater associated risk of developing diabetes and hypertension compared with adults. High between-study heterogeneity was a concern for several meta-analyses. Conclusions and Relevance Results suggest that the associated increased risk of cardiometabolic diseases should prompt clinicians to vigilantly monitor individuals with autism for potential contributors, signs of cardiometabolic disease, and their complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Autism Spectrum DisorderAutistic DisorderStrokeHypertensionHeart DiseasesAdultChildHumansFemaleObesity

Autor:innen und Institutionen

  • Department of Laboratory Science and Primary Care, School of Health Professions, Texas Tech University Health Sciences Center, Lubbock.
  • Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock.
  • Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock.
  • Department of Psychiatry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock.
  • Department of Human Development and Family Sciences, College of Human Sciences, Texas Tech University, Lubbock.
  • Department of Neurology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock.

Zitieren

APA

Dhanasekara, C. S., Ancona, D., Cortes, L., Hu, A., Rimu, A. H., Robohm-Leavitt, C., Payne, D., Wakefield, S. M., Mastergeorge, A. M., & Kahathuduwa, C. N. (2023). Association Between Autism Spectrum Disorders and Cardiometabolic Diseases. JAMA Pediatrics, 177(3), 248. https://doi.org/10.1001/jamapediatrics.2022.5629

Vancouver

Dhanasekara CS, Ancona D, Cortes L, Hu A, Rimu AH, Robohm-Leavitt C, et al. Association Between Autism Spectrum Disorders and Cardiometabolic Diseases. JAMA Pediatrics. 2023;177(3):248. doi:10.1001/jamapediatrics.2022.5629

BibTeX
@article{Dhanasekara2023,
  author = {Dhanasekara, Chathurika S and Ancona, Dominic and Cortes, Leticia and Hu, Amy and Rimu, Afrina H and Robohm-Leavitt, Christina and Payne, Drew and Wakefield, Sarah M and Mastergeorge, Ann M and Kahathuduwa, Chanaka N},
  title = {Association Between Autism Spectrum Disorders and Cardiometabolic Diseases},
  journal = {JAMA Pediatrics},
  year = {2023},
  volume = {177},
  number = {3},
  pages = {248},
  doi = {10.1001/jamapediatrics.2022.5629}
}
Kostenlos starten →